NIH VideoCast - Curing HIV infection: going beyond N=1

Skip Navigation

Curing HIV infection: going beyond N=1

Loading... Loading video...

416 Views

Air date:	Wednesday, February 1, 2017, 4:15:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 416 (78 Live, 338 On-demand)
Category:	Immunology
Runtime:	00:57:36
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Immunology Interest Group Seminar Series The latent reservoir for HIV is a major barrier to curing HIV infection. This talk will discuss recent studies of the mechanism by which the reservoir arises, the mechanism by which it is maintained, and approaches for measuring the reservoir in patients participating in HIV cure trials. Dr. Robert F. Siliciano is a Professor of Medicine and Molecular Biology and Genetics at the Johns Hopkins University School of Medicine and a member of the Howard Hughes Medical Institute. In 1995, his laboratory provided the first demonstration that latently infected memory CD4+ T cells were present in patients with HIV-1 infection. He showed that latently infected cells persist even in patients on prolonged antiretroviral therapy (ART). These studies indicated that eradication of HIV-1 infection with ART alone would never be possible, a finding which led to a fundamental change in the treatment strategy for HIV-1 infection. This latent reservoir is now recognized as the major barrier to curing HIV-1 infection and is the subject of an intense international research effort. Dr. Siliciano’s laboratory has gone on to characterize the reservoir and to explore strategies for eradicating it. In addition, Dr. Siliciano has developed a theoretical foundation for understanding the success of ART in controlling HIV-1 replication. Dr. Siliciano graduated from Princeton and received his MD and PhD degrees from Johns Hopkins. After a postdoctoral fellowship at Harvard, he joined the Hopkins faculty. He has received the Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation and two NIH Merit Awards. He is a past Chairman of the NIH AIDS and Related Research Study Section. For 16 years, he directed the Hopkins MD-PhD Program, and he now serves as an advisor for MDPhD students. In 2008, he received a major award in AIDS research, the Bernard N. Fields Memorial Lecture at the Conference for Retroviruses and Opportunistic Infections.

NLM Title:	Curing HIV infection : going beyond N=1 / Robert F. Siliciano ; Immunology Interest Group.
Author:	Siliciano, Robert F. National Institutes of Health (U.S.). Immunology Interest Group,
Publisher:
Abstract:	(CIT): Immunology Interest Group Seminar Series The latent reservoir for HIV is a major barrier to curing HIV infection. This talk will discuss recent studies of the mechanism by which the reservoir arises, the mechanism by which it is maintained, and approaches for measuring the reservoir in patients participating in HIV cure trials. Dr. Robert F. Siliciano is a Professor of Medicine and Molecular Biology and Genetics at the Johns Hopkins University School of Medicine and a member of the Howard Hughes Medical Institute. In 1995, his laboratory provided the first demonstration that latently infected memory CD4+ T cells were present in patients with HIV-1 infection. He showed that latently infected cells persist even in patients on prolonged antiretroviral therapy (ART). These studies indicated that eradication of HIV-1 infection with ART alone would never be possible, a finding which led to a fundamental change in the treatment strategy for HIV-1 infection. This latent reservoir is now recognized as the major barrier to curing HIV-1 infection and is the subject of an intense international research effort. Dr. Siliciano"s laboratory has gone on to characterize the reservoir and to explore strategies for eradicating it. In addition, Dr. Siliciano has developed a theoretical foundation for understanding the success of ART in controlling HIV-1 replication. Dr. Siliciano graduated from Princeton and received his MD and PhD degrees from Johns Hopkins. After a postdoctoral fellowship at Harvard, he joined the Hopkins faculty. He has received the Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation and two NIH Merit Awards. He is a past Chairman of the NIH AIDS and Related Research Study Section. For 16 years, he directed the Hopkins MD-PhD Program, and he now serves as an advisor for MDPhD students. In 2008, he received a major award in AIDS research, the Bernard N. Fields Memorial Lecture at the Conference for Retroviruses and Opportunistic Infections.
Subjects:	Antiviral Agents--immunology CD4-Positive T-Lymphocytes--immunology Drug Resistance, Viral HIV Infections--drug therapy HIV Infections--immunology
Publication Types:	Lecture Webcast

NLM Classification:	WC 503.2
NLM ID:	101702155
CIT Live ID:	18548
Permanent link:	https://videocast.nih.gov/watch=18548

Related Videos...